世界の尿路カテーテル市場:医療機器パイプライン分析2016

◆英語タイトル:Urinary Catheters - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0201EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年6月1日
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、尿路カテーテルのグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・尿路カテーテルの概要
・尿路カテーテルの開発動向:開発段階別分析
・尿路カテーテルの開発動向:セグメント別分析
・尿路カテーテルの開発動向:領域別分析
・尿路カテーテルの開発動向:規制Path別分析
・尿路カテーテルの開発動向:承認日(推定)別分析
・企業別尿路カテーテルの開発動向(パイプライン製品、進行中の治験)
・尿路カテーテルの最近動向
【レポートの概要】

Urinary Catheters – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Urinary Catheters – Medical Devices Pipeline Assessment, 2016″ provides an overview of Urinary Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Urinary Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Urinary Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Urinary Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Urinary Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Urinary Catheters Overview 6
3 Products under Development 7
3.1 Urinary Catheters – Pipeline Products by Stage of Development 7
3.2 Urinary Catheters – Pipeline Products by Segment 8
3.3 Urinary Catheters – Pipeline Products by Territory 9
3.4 Urinary Catheters – Pipeline Products by Regulatory Path 10
3.5 Urinary Catheters – Pipeline Products by Estimated Approval Date 11
4 Urinary Catheters – Pipeline Products under Development by Companies 12
4.1 Urinary Catheters Companies – Pipeline Products by Stage of Development 12
4.2 Urinary Catheters – Pipeline Products by Stage of Development 13
5 Urinary Catheters Companies and Product Overview 14
5.1 Applied Catheter Technologies Inc. Company Overview 14
5.1.1 Applied Catheter Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 15
5.2.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Enox Biopharma, Inc Company Overview 16
5.3.1 Enox Biopharma, Inc Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 FocusStart LLC Company Overview 17
5.4.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 Marvao Medical Devices Limited Company Overview 18
5.5.1 Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 18
5.6 Olympus Medical Systems Corp. Company Overview 19
5.6.1 Olympus Medical Systems Corp. Pipeline Products & Ongoing Clinical Trials Overview 19
5.7 Sharklet Technologies, Inc. Company Overview 20
5.7.1 Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
5.8 Teleflex Incorporated Company Overview 21
5.8.1 Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview 21
5.9 The University of Utah Company Overview 23
5.9.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 23
5.10 University of California, San Diego Company Overview 24
5.10.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 24
5.11 University of Nottingham Company Overview 25
5.11.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 25
5.12 Urovalve, Inc. Company Overview 26
5.12.1 Urovalve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.13 Xennovate Medical LLC Company Overview 28
5.13.1 Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 28
6 Urinary Catheters- Recent Developments 30
6.1 May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivation’s Board 30
6.2 May 23, 2016: Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020 33
6.3 May 23, 2016: New Distribution Partnership for Edward-Elmhurst Health’s Physician Offices Results in Cost Savings of 10 Percent 33
6.4 May 16, 2016: Hollister Hires Carolin Archibald for Newly Created Position of Vice President of U.S. and Canada 34
6.5 May 13, 2016: ConvaTec Healthcare May Raise USD1 Billion in IPO 34
6.6 May 12, 2016: Bactiguard Holding: Interim Report For Q1 2016 34
6.7 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 36
6.8 May 04, 2016: C. R. Bard Prices Public Offering of 3% Notes Due 2026 for USD500 Million 36
6.9 May 04, 2016: Hollister Announces Settlement Agreement 36
6.10 May 03, 2016: Coloplast delivers H1 result in line with expectations 37
6.11 Apr 28, 2016: Teleflex Reports First Quarter 2016 Results 37
6.12 Apr 27, 2016: Bard Announces First Quarter Results 39
6.13 Apr 18, 2016: Henry Ford Breast Cancer Program Granted 3-Year Accreditation 39
6.14 Apr 05, 2016: Allegiance Health Joins Henry Ford Health System 40
6.15 Mar 09, 2016: Coloplast gets breakthrough with continence business in Japan 40
6.16 Feb 25, 2016: Teleflex Reports Fourth Quarter and Full Year 2015 Results; Provides 2016 Guidance 41
6.17 Feb 02, 2016: Coloplast delivers Q1 results in line with guidance 42
6.18 Jan 29, 2016: Bard Announces Fourth Quarter Results 43
6.19 Jan 21, 2016: First order from China Announced By Bactiguard 44
6.20 Jan 19, 2016: Leading Medical Device Companies Select Brainshark to Drive Sales Productivity 44
6.21 Jan 05, 2016: Argon Medical Devices Acquires Three Vascular Products from Rex Medical 45
6.22 Jan 05, 2016: Kane Biotech appoints new CFO and announces addition of Commercialization Team Resources, Sales Representation Agreement for U.S. Market Expansion, and Grant of Options 45
6.23 Jan 04, 2016: Product approval opens door to China 46
6.24 Dec 23, 2015: Coloplast settles with the U.S. Department of Justice 46
6.25 Dec 09, 2015: Bactiguard Holding : Major Order from India 47
6.26 Dec 09, 2015: Bactiguard Holding: Large Clinical Study Starting in India 47
6.27 Dec 07, 2015: Comfort Medical Acquires Medical Direct Club 48
6.28 Nov 30, 2015: Covalon Announces FDA Clearance for Its New SilverCoat Silicone Foley Catheter 48
6.29 Nov 30, 2015: Teleflex to focus on showcasing its Intraosseous and Central Vascular Access portfolio featuring chlorhexidine based technologies at GAVeCeLT 2015 – December 1-3, in Milan, Italy 48
6.30 Nov 03, 2015: Coloplast delivers full-year results in line with guidance 49
6.31 Oct 29, 2015: Teleflex Reports Third Quarter 2015 Results 50
6.32 Oct 22, 2015: Bard Announces Third Quarter Results 51
6.33 Oct 20, 2015: ConvaTec Introduces GentleCath Pro Closed-System Intermittent Catheter 51
6.34 Oct 02, 2015: Ambu announces partnership with Coloplast on visualization product for the urology market 52
6.35 Sep 15, 2015: Coloplast Launches New Continence Care Product – Speedicath Compact Male – in the United States 52
6.36 Aug 17, 2015: Teleflex Signs New Agreement with Amerinet for Surgical Instruments 53
6.37 Jul 30, 2015: Teleflex Reports Second Quarter 2015 Results 53
6.38 Jul 23, 2015: Bard Announces Second Quarter Results 54
6.39 Jul 21, 2015: FDA Issues Warning Letter To C. R. Bard 55
6.40 Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean 55
6.41 Jun 24, 2015: Innovative Duette Urinary Drainage System to be Featured at APIC Annual Meeting 56
7 Appendix 58
7.1 Methodology 58
7.2 About GlobalData 60
7.3 Contact Us 61
7.4 Disclaimer 61

1.1 List of Tables
Table 1: Urinary Catheters - Pipeline Products by Stage of Development 7
Table 2: Urinary Catheters - Pipeline Products by Segment 8
Table 3: Urinary Catheters - Pipeline Products by Territory 9
Table 4: Urinary Catheters - Pipeline Products by Regulatory Path 10
Table 5: Urinary Catheters - Pipeline Products by Estimated Approval Date 11
Table 6: Urinary Catheters Companies - Pipeline Products by Stage of Development 12
Table 7: Urinary Catheters - Pipeline Products by Stage of Development 13
Table 8: Applied Catheter Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
Table 9: Drug Coated Catheter - Product Status 14
Table 10: Drug Coated Catheter - Product Description 14
Table 11: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 15
Table 12: Cerashield Coated Silicone Urinary Catheter - Product Status 15
Table 13: Cerashield Coated Silicone Urinary Catheter - Product Description 15
Table 14: Enox Biopharma, Inc Pipeline Products & Ongoing Clinical Trials Overview 16
Table 15: Self-Sterilizing Urinary Catheter - Product Status 16
Table 16: Self-Sterilizing Urinary Catheter - Product Description 16
Table 17: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 17
Table 18: Anti-biofilm Urological Catheter - Product Status 17
Table 19: Anti-biofilm Urological Catheter - Product Description 17
Table 20: Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 18
Table 21: NexSite Drainage Catheter - Product Status 18
Table 22: NexSite Drainage Catheter - Product Description 18
Table 23: Olympus Medical Systems Corp. Pipeline Products & Ongoing Clinical Trials Overview 19
Table 24: Uro-Ease - Product Status 19
Table 25: Uro-Ease - Product Description 19
Table 26: Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
Table 27: Foley Urinary Catheter - Product Status 20
Table 28: Foley Urinary Catheter - Product Description 20
Table 29: Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview 21
Table 30: Pre-Activated Female Intermittent Catheter - Product Status 21
Table 31: Pre-Activated Female Intermittent Catheter - Product Description 22
Table 32: Pre-Activated Male Intermittent Catheter - Product Status 22
Table 33: Pre-Activated Male Intermittent Catheter - Product Description 22
Table 34: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 23
Table 35: AdvanceCath Catheter - Product Status 23
Table 36: AdvanceCath Catheter - Product Description 23
Table 37: University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 24
Table 38: Urethral Catheter - Product Status 24
Table 39: Urethral Catheter - Product Description 24
Table 40: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 25
Table 41: Antimicrobial Catheter - Product Status 25
Table 42: Antimicrobial Catheter - Product Description 25
Table 43: Urovalve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
Table 44: FolEase Catheter - Product Status 26
Table 45: FolEase Catheter - Product Description 26
Table 46: Surinate Bladder Management System - Product Status 27
Table 47: Surinate Bladder Management System - Product Description 27
Table 48: Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 28
Table 49: ProSeal Ultra Condom Catheter - Product Status 28
Table 50: ProSeal Ultra Condom Catheter - Product Description 28
Table 51: Vortex ZDS Urinary Retention Catheter - Product Status 29
Table 52: Vortex ZDS Urinary Retention Catheter - Product Description 29
Table 53: Glossary 59

1.2 List of Figures
Figure 1: Urinary Catheters - Pipeline Products by Stage of Development 7
Figure 2: Urinary Catheters - Pipeline Products by Segment 8
Figure 3: Urinary Catheters - Pipeline Products by Territory 9
Figure 4: Urinary Catheters - Pipeline Products by Regulatory Path 10
Figure 5: Urinary Catheters - Pipeline Products by Estimated Approval Date 11

【掲載企業】

Applied Catheter Technologies Inc.
Ceragenix Pharmaceuticals, Inc.
Enox Biopharma, Inc
FocusStart LLC
Marvao Medical Devices Limited
Olympus Medical Systems Corp.
Sharklet Technologies, Inc.
Teleflex Incorporated
The University of Utah
University of California, San Diego
University of Nottingham
Urovalve, Inc.
Xennovate Medical LLC

★調査レポート[世界の尿路カテーテル市場:医療機器パイプライン分析2016]販売に関する免責事項
★調査レポート[世界の尿路カテーテル市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆